Pharmaceutical giant Dr Reddy's Laboratories Ltd on 26 October 2016 announced that it entered into a strategic collaboration with Gland Pharma. The companies entered into the deal to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications (ANDAs).
The portfolio is a mix of filed ANDAs pending approval by the US Food and Drug Administration (USFDA) and ANDAs that will be filed imminently. The portfolio comprised of generic injectables administered in hospitals and clinics in the US.
About Dr Reddy's Laboratories
• Dr Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad, Telangana.
• The company was founded by Anji Reddy, who previously worked in the mentor institute, Indian Drugs and Pharmaceuticals Limited.
• Dr Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas.
• The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care and biotechnology products.
When: 26 October 2016
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.